TW2Informatics 


Christopher Southan

TW2Informatics

3Q 2024 updates;  now registered for F-Skatt as a Swedish  company (but still some hoops to go through before raising invoices). TW2 was was first set up in 2007  as UK Company Number 6451671 and  closed down in 2021  for the duration of my MDC employment.  I have used this affiliation in past publications  (8 in PubMed) and presentations 

Current News:   August 2024 appointed Honorary Professor at the University of Edinburgh, Deanery of Biomedical Sciences.

Older news: June 2020  contract work for Medicines Discovery Catapult ,  Jan 2020,   University of New Mexico became a new client.    Nov 2019,  passed the magic 100 papers in PubMed and awarded Clarivate "Highly Cited Researcher" (again)  for 2019, Sept 2019,  appointed  Honorary Fellow, University of Edinburgh  in the  Deanery of Biomedical Sciences,  August  2019,  work completed for a new customer  Novaremed,  July  2019 ;  Completed a substantial  Academic Drug Development  report now  on  ChemRxiv,  commissioned  by  Karolinska Institute, Stockholm  and IUPHAR ,   August 2018;  appointed  Adjunct Assistant  Professor at the University of New Mexico  Department of  Internal Medicine

Introduction:  My  consulting value  is derived  from being an accomplished senior scientist with a multidisciplinary background. As well as successes in team management and project leadership I have  a documented achievement  record  in data mining,  biocuration,  bioinformatics, cheminformatics, proteomics,  genomics, bioactive chemistry databases, drug target discovery and protein chemistry. My  experience and broad contact network encompasses both the scientific, strategic  and commercial aspects of pharmaceutical and biotechnology R&D.  Past clients have included the AstraZeneca Knowledge Engineering Program and SureChem (ex Digital Science and precursor of SureChEMBL)

Background:  see LinkedIN profile, including a CV outline,  advisory board memberships,  recent publications  and open recommendations

Previous recent position:  Competitive Intelligence Analyst, Informatics,  Medicines Discovery Catapult,  Senior Cheminformatican for the IUPHAR/BPS Guide to PHARMACOLOGY database  (May  2013 to October 2018)  within the   Deanery of Biomedical Sciences,  Edinburgh University,  Scotland but working remotely from Sweden

Publications:   PubMed  Southan C  has 119 PMIDS  (as of  July 2024 ),  ORCID ID 0000-0001-9580-0446  with an h-index of  64 on  Google Scholar

Blog:  Bio < > Chem  should be of interest and  provides a technical expertise showcase 

Presentations: Zendo  https://zenodo.org/search?q=Christopher%20Southan&l=list&p=1&s=10&sort=newest  plus older ones still on  Slideshare

Twitter:  https://twitter.com/cdsouthan

Contact:  cdsouthan@gmail.com  mobile (Sweden) 0046-702-530710,  resident in Göteborg , Sweden, 42166.  

 

 Specialist Areas